FineMark National Bank & Trust’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-954
Closed -$47K – 1015
2016
Q4
$47K Hold
954
– – ﹤0.01% 639
2016
Q3
$50K Hold
954
– – 0.01% 604
2016
Q2
$43K Buy
954
+554
+139% +$24.1K ﹤0.01% 633
2016
Q1
$16K Hold
400
– – ﹤0.01% 818
2015
Q4
$15K Hold
400
– – ﹤0.01% 872
2015
Q3
$13K Hold
400
– – ﹤0.01% 935
2015
Q2
$15K Hold
400
– – ﹤0.01% 943
2015
Q1
$14K Hold
400
– – ﹤0.01% 942
2014
Q4
$15K Hold
400
– – ﹤0.01% 959
2014
Q3
$14K Hold
400
– – ﹤0.01% 960
2014
Q2
$16K Hold
400
– – ﹤0.01% 949
2014
Q1
$15K Hold
400
– – ﹤0.01% 964
2013
Q4
$14K Hold
400
– – ﹤0.01% 943
2013
Q3
$11K Hold
400
– – ﹤0.01% 961
2013
Q2
$11K Buy
+400
New +$11K ﹤0.01% 941

Other funds holding XYL

FineMark National Bank & Trust's XYL Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Xylem (XYL) in Q1 2017, closing a stake of 954 shares — an estimated $47K sold.

FineMark National Bank & Trust first reported a position in XYL in Q2 2013 and held it in 15 quarters. The position peaked at $50K in Q3 2016. 547 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 954 Xylem shares in Q1 2017, an estimated $47K.
  • FineMark National Bank & Trust first reported a position in Xylem in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Xylem position peaked at $50K in Q3 2016.
  • 547 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.